search

Active clinical trials for "Arthritis, Psoriatic"

Results 411-420 of 469

A Study to Assess the Safety and Effectiveness of Golimumab in Filipino Patients With Rheumatoid...

Rheumatoid ArthritisPsoriatic Arthritis1 more

The purpose of this study is to assess the safety and effectiveness of golimumab for the treatment of rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis among Filipino patients.

Withdrawn9 enrollment criteria

Psoriatic Arthritis Treat to Target vs. Usual Care

Psoriatic Arthritis (PsA)

Canadian Rheumatologists will be randomized to treat their participants with active Psoriatic Arthritis to a target (disease activity score <2.6), or as per their routine care. The aim of this study is to determine whether treating to a target results in greater disease improvement than treating patients using routine care.

Withdrawn8 enrollment criteria

Safety and Effectiveness and Effect on Quality of Life and Work Productivity of Humira in Patients...

Psoriatic Arthritis

Safety and effectiveness, quality of life and work productivity of Humira in patients with psoriatic arthritis in clinical routine.

Withdrawn4 enrollment criteria

Tracking Biologics Along the Silk Road

ArthritisRheumatoid; Spondylitis3 more

The objective of this study is to explore and describe the disease characteristics, treatment and outcomes of participants with rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, Crohn's Disease or ulcerative colitis as the major disease treated with REMICADE, SIMPONI or STELARA in clinical practice in the emerging regions of North Africa, the Middle East, and Western Asia.

Completed7 enrollment criteria

National Observational Study On The Use Of Inflectra™ An Infliximab Biosimilar In Real Life

Crohn DiseaseUlcerative Colitis3 more

National, prospective, multicentre observational study designed for eligible patients treated with Inflectra. Its objectives are to describe under real conditions of use, the profile of patients treated with Inflectra and the response to treatment.

Completed9 enrollment criteria

One-year Persistence to Treatment of Participants Receiving Flixabi or Imraldi: a French Cohort...

ArthritisRheumatoid7 more

A study to describe the one-year persistence in participants treated by Flixabi (infliximab) or Imraldi (Adalimumab) as prescribed by the physician for each of the 5 following indications: Rheumatoid Arthritis (RA), Ankylosing Spondylitis (AS), Psoriatic Arthritis (PsA), Crohn's Disease (CD) [adults and children] and Ulcerative Colitis (UC) [adults for both treatments and children only for Flixabi].

Completed16 enrollment criteria

Evaluating of New Screening Tool for Arthritis* in Psoriasis

PsoriasisPsoriatic Arthritis

This study evaluates a new screening tool for arthritis in psoriasis and compares its reliability with well-known screening tool (TOPAS 2).

Completed3 enrollment criteria

Clinical and Dermoscopic Comparison of Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriasis...

Psoriasis CircinataPsoriatic Arthritis3 more

This study evaluates the fingernail findings of the rheumatoid arthritis, spondylopathy and psoriatic arthritis patient groups with the fingernails of psoriasis patients clinically and dermatoscopically and investigates the benefit of dermoscopy in the differentiation of these patients.

Completed5 enrollment criteria

Carpal Tunnel Syndrome in Patients With Psoriatic Arthritis

Carpal Tunnel SyndromePsoriatic Arthritis

This study aimed to investigate median nerve hypervasculatitation in psoriatic arthritis (PsA) patients with CTS or without CTS by using SMI, then compare them with normal people.

Completed2 enrollment criteria

Exploratory Study on Quality of Life in Patient With Moderate Psoriasis and Moderate Psoriatic Arthritis...

Psoriatic ArthritisPsoriasis

This exploratory study will be used to identify questions that will be part of a new QoL questionnaire for patients with psoriasis and psoriatic arthritis and to determine the sample size needed for its validation. The new questionnaire will be a global QoL questionnaire which will take into account the impact of both psoriasis and psoriatic arthritis on QoL. STUDY OBJECTIVES To evaluate the influence of psoriasis and psoriatic arthritis on patient's answers to QoL questions from DLQI, HAQ, EQ-5D, FACIT-fatigue and SF-36. To identify an equal number of questions from DLQI, HAQ, EQ-5D, FACIT-fatigue and SF-36 where answers are mostly influenced either by psoriatic arthritis or by psoriasis.

Completed17 enrollment criteria
1...414243...47

Need Help? Contact our team!


We'll reach out to this number within 24 hrs